MCID: UTR006
MIFTS: 15

Uterine Inflammatory Disease malady

Categories: Reproductive diseases

Aliases & Classifications for Uterine Inflammatory Disease

Aliases & Descriptions for Uterine Inflammatory Disease:

Name: Uterine Inflammatory Disease 12 14
Inflammatory Disease of the Uterus 12 69

Classifications:



External Ids:

Disease Ontology 12 DOID:13736
ICD10 33 N71.9
ICD9CM 35 615.9
UMLS 69 C0269047

Summaries for Uterine Inflammatory Disease

MalaCards based summary : Uterine Inflammatory Disease, is also known as inflammatory disease of the uterus. An important gene associated with Uterine Inflammatory Disease is YBX3 (Y-Box Binding Protein 3). The drugs Ketorolac and Mefenamic acid have been mentioned in the context of this disorder. Affiliated tissues include uterus.

Related Diseases for Uterine Inflammatory Disease

Diseases in the Uterine Disease family:

Uterine Inflammatory Disease

Comorbidity relations with Uterine Inflammatory Disease via Phenotypic Disease Network (PDN):


Acute Cystitis

Symptoms & Phenotypes for Uterine Inflammatory Disease

Drugs & Therapeutics for Uterine Inflammatory Disease

Drugs for Uterine Inflammatory Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 285)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ketorolac Approved Phase 4,Phase 2 74103-06-3, 66635-83-4 3826
2
Mefenamic acid Approved Phase 4,Phase 3 61-68-7 4044
3
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
4
Povidone-iodine Approved Phase 4,Phase 3 25655-41-8
5
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
6
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757 53477783
7
Levonorgestrel Approved, Investigational Phase 4 797-63-7, 17489-40-6 13109
8
Naproxen Approved, Vet_approved Phase 4 22204-53-1 1302 156391
9
Acetaminophen Approved Phase 4,Phase 2 103-90-2 1983
10
Ibuprofen Approved Phase 4 15687-27-1 3672
11
Flurbiprofen Approved, Investigational Phase 4 5104-49-4 3394
12
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
13
Tranexamic Acid Approved Phase 4 1197-18-8 5526
14
Cisplatin Approved Phase 4,Phase 1,Phase 2 15663-27-1 84093 441203 2767
15
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 2 50-02-2 5743
16
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-78-2 2244
17
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
18
Celecoxib Approved, Investigational Phase 4,Phase 1,Phase 2 169590-42-5 2662
19
Azithromycin Approved Phase 4,Phase 3 83905-01-5 55185 53477736 447043
20
Cefazolin Approved Phase 4 25953-19-9 656510 33255
21
Copper Approved Phase 4 15158-11-9, 7440-50-8 27099
22
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
23
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
24
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 68602 5311068 56032
25
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
26
Nitrous oxide Approved, Vet_approved Phase 4 10024-97-2 948
27
Pregabalin Approved, Illicit, Investigational Phase 4 148553-50-8 5486971
28 Anti-Infective Agents Phase 4,Phase 2,Phase 3,Phase 1
29 Micronutrients Phase 4,Phase 3,Phase 2
30 Trace Elements Phase 4,Phase 3,Phase 2
31 Anti-Bacterial Agents Phase 4,Phase 2,Phase 3,Phase 1
32 Analgesics Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
33 Analgesics, Non-Narcotic Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
34 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
35 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
36 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
37 Cyclooxygenase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
38 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
39 Ketorolac Tromethamine Phase 4,Phase 2
40 Anesthetics Phase 4,Phase 2,Early Phase 1
41 Central Nervous System Depressants Phase 4,Phase 2,Early Phase 1
42 Autonomic Agents Phase 4,Phase 2
43 Anesthetics, Local Phase 4,Phase 2
44 Mydriatics Phase 4
45 Neurotransmitter Agents Phase 4,Phase 2
46 Antibiotics, Antitubercular Phase 4,Phase 2,Phase 3
47 Antitubercular Agents Phase 4,Phase 2,Phase 3
48 Clindamycin palmitate Phase 4
49 Clindamycin phosphate Phase 4
50 Gentamicins Phase 4,Phase 2,Phase 3

Interventional clinical trials:

(show top 50) (show all 126)
id Name Status NCT ID Phase
1 Comparative Study of Mesh Versus No Mesh in Prolapse Surgery Unknown status NCT00153257 Phase 4
2 Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease Completed NCT01034358 Phase 4
3 Does Preoperative Vaginal Preparation With Povidone-iodine Before Cesarean Delivery Reduce the Risk of Endometritis? Completed NCT01437228 Phase 4
4 Doxycycline Prophylaxis at Vacuum Aspiration Trial Completed NCT00547170 Phase 4
5 Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia Completed NCT01165307 Phase 4
6 Effectiveness of IV Acetaminophen and IV Ibuprofen in Reducing Post Procedural Pain in the UFE Procedure Completed NCT02227316 Phase 4
7 Flurbiprofen Axetil for Uterine Contraction Pain Completed NCT00725218 Phase 4
8 Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA) Completed NCT01295294 Phase 4
9 Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment Completed NCT01372904 Phase 4
10 Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers Completed NCT01729468 Phase 4
11 Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia Completed NCT01352234 Phase 4
12 Surgical Success After Laparoscopic vs Abdominal Hysterectomy Recruiting NCT01793584 Phase 4
13 Preoperative Vaginal Cleansing With Povidone Iodine and the Risk of Post Cesarean Endometritis Recruiting NCT02693483 Phase 4
14 Copper IUD Treatment Observation Study Recruiting NCT02519231 Phase 4
15 TAP vs Surgical Infiltration of Local Anesthetic in Laparoscopic and Robotic Hysterectomy Recruiting NCT02519023 Phase 4
16 Effects of Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on Cytokines Not yet recruiting NCT03164590 Phase 4
17 Treatment Utility of Postpartum Antibiotics in Chorioamnionitis Terminated NCT01585129 Phase 4
18 Peritoneal Cavity Conditioning Decreases Pain, Inflammation and Adhesions Terminated NCT01344486 Phase 4
19 Preemptive Analgesia Following Uterine Artery Embolization Terminated NCT01555073 Phase 4
20 Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis Withdrawn NCT01721616 Phase 4
21 Local Endometrial Injury in Fresh Embryo Transfer Cycles Unknown status NCT01844453 Phase 3
22 Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination Completed NCT00964210 Phase 3
23 Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term Completed NCT01633294 Phase 2, Phase 3
24 The Effect of Low Dose Aspirin in Increasing the Chance of Pregnancy Completed NCT01633528 Phase 3
25 Chlorhexidine Gluconate vs Povidone-Iodine Vaginal Cleansing Solution Prior to Cesarean Delivery Recruiting NCT02915289 Phase 3
26 Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause Not yet recruiting NCT02943655 Phase 3
27 Empiric Therapy of Mucopurulent Cervicitis (MPC) Terminated NCT01072136 Phase 3
28 Perioperative Ketorolac-lidocaine in the Patients With Valvular Heart Diseases During Cesarean Delivery Unknown status NCT01571791 Phase 2
29 The Efficacy of Viburnum Opulus 3X in the Treatment of Primary Dysmenorrhea Completed NCT02467543 Phase 2
30 Role of Ginkgo Biloba Extract in IUGR Completed NCT02425436 Phase 2
31 Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) Completed NCT00332033 Phase 2
32 Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of Gestation Completed NCT01616615 Phase 2
33 The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth Restriction Completed NCT02696577 Phase 2
34 Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers Completed NCT00319748 Phase 2
35 Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 Completed NCT02150213 Phase 2
36 Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma Completed NCT00050440 Phase 2
37 Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma Completed NCT02017353 Phase 2
38 Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the Cervix Completed NCT00152828 Phase 1, Phase 2
39 Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer Completed NCT00023660 Phase 1, Phase 2
40 Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial. Completed NCT02280031 Phase 2
41 Papillary Serous Carcinoma of the Endometrium Completed NCT00515073 Phase 2
42 Hysteroscopic Tubal Occlusion Using Iso-Amyl 2-Cyano Acrylate (Amcrylate) in Patients With Hydrosalpinx Recruiting NCT02977234 Phase 1, Phase 2
43 Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne Recruiting NCT03076320 Phase 1, Phase 2
44 Paracetamol With or Without Ketoprofen in the Management of Pain for Patients Receiving Brachytherapy (KETOCOL-1304) Recruiting NCT02439034 Phase 2
45 Dexamethasone for Excessive Menstruation Recruiting NCT01769820 Phase 2
46 Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer Active, not recruiting NCT00445965 Phase 2
47 Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia Active, not recruiting NCT00081263 Phase 2
48 The Optimal Time for Intravenous Antibiotic Prophylaxis in Elective Cesarean Section Not yet recruiting NCT02742948 Phase 2
49 Impact of the Administration of Fludrocortisone in Very Premature Infants Not yet recruiting NCT03001089 Phase 2
50 Nefopam vs Tramadol in the Prevention of Post Anaesthetic Shivering Not yet recruiting NCT02441673 Phase 2

Search NIH Clinical Center for Uterine Inflammatory Disease

Genetic Tests for Uterine Inflammatory Disease

Anatomical Context for Uterine Inflammatory Disease

MalaCards organs/tissues related to Uterine Inflammatory Disease:

39
Uterus

Publications for Uterine Inflammatory Disease

Variations for Uterine Inflammatory Disease

Expression for Uterine Inflammatory Disease

Search GEO for disease gene expression data for Uterine Inflammatory Disease.

Pathways for Uterine Inflammatory Disease

GO Terms for Uterine Inflammatory Disease

Sources for Uterine Inflammatory Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....